You are in:Home/Publications/Hepatoprotective Effects of Cranberry Extract against Diclofenac Sodium Induced Liver Toxicity in Rats

Prof. Hussein Abd Elmaksoud Ali :: Publications:

Title:
Hepatoprotective Effects of Cranberry Extract against Diclofenac Sodium Induced Liver Toxicity in Rats
Authors: Abdel-Maksoud A. Hussien1, Mohammed Abdalla Hussein*2, Naglaa Abd El Khalik Gobba3 and Mahmoud Rabie Ahmed1
Year: 2016
Keywords: Diclofenac sodium, liver toxicity, cranberry, Antioxidant enzymes, lipid profile, GSH.
Journal: Intternattiionall Journall of Pharma Sciiences
Volume: Vol. 6
Issue: No. 2 (2016)
Pages: 1447-1453
Publisher: aizeon publisher
Local/International: International
Paper Link:
Full paper Hussein Abd Elmaksoud Ali_40.pdf
Supplementary materials Not Available
Abstract:

ABSTRACT The present study was to evaluate hepatoprotective effects of cranberry extract (75 and 150mg/kg.b.w) against Diclofenac sodium induced liver toxicity in rats. Oral administration of Diclofenac sodium (150mg/kg.b.w.) led to significant increase in plasma transaminases (L-alanine and L-aspartate), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), tumor necrosis factor-alfa (TNF-α), nitric oxide (NO) and TBARS as well as plasma, triglyceride, total cholesterol, and LDL-cholesterol. Also, treatment of rats with Diclofenac sodium led to significant decrease in liver GSH, Protein thiols (Pr-SHs), superoxide dismutase (SOD), catalase (CAT) as well as plasma HDL. The obtained result revealed that cranberry extract (75 and 150mg/kg.b.w.) prevent liver tissue damage through increasing of GSH, SOD and CAT activities and decrease significantly TBARs level. These results suggest that, cranberry may be effective in enhances the protection of liver toxicity by its radical scavenging effect and antioxidant activity.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus